ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

William Sandborn  1     Bal R. Bhandari  2     Charles Randall  3     Ziad Younes  4     Tomasz RomaƄczyk  5     Hao Chai  6     Matthew McKevitt     Sally Zhao     Bittoo Kanwar     John Sundy     Satish Keshav     Silvio Danese    
1 University of California,San Diego,United States of America
2 Delta Research Partners,Monroe,United States of America
3 Gastroenterology Research of America/U. of Texas,San Antonio,United States of America
4 GastroOne,Germantown,United States of America
5 Takeda Polska Sp. z o.o.,Tychy,Poland
6 Gilead Sciences,Foster City,United States of

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing